Rejuvenation Revelation: Unlocking the Code to Ageless Beauty – Episode 238

RECTIFICATION: There is a part of the conversation in this episode where Dr. Gladden asks Dr. Zonari how much more potent is the OneSkin OS-01 EYE product and Dr. Zonari said it is twice as potent. However, Dr. Zonari, in her compromise of being honest and responsible with the audience, reached out after recording with more accurate information for her answer. The OneSkin OS-01 EYE product has 25% more concentration than the OS-01.

Welcome to the Gladden Longevity Podcast! In this episode, the hosts, Steve Reiter and Dr.Jeffery Gladden as they, talk with Alessandra Zonari. Dr. Alessandra is the Co-Founder and Chief Scientific Officer of OneSkin, a skin longevity company. Founded by a team of female PhD-level scientists, OneSkin focuses on developing products to address aging’s root causes. Their discovery of OS-01, the world’s first cosmetic peptide that reverses aging at the molecular level, has garnered significant attention. With $13M in funding, they have launched multiple products and gained recognition from key opinion leaders in longevity science and major media outlets. Dr. Alessandra holds a Master’s degree and a Ph.D. in related fields and is known for her groundbreaking work in skin regeneration and tissue engineering. In this episode we delve into the pioneering work of this disruptive skin longevity company, revolutionizing anti-aging skincare with their innovative approach. Discover how their team of female PhD-level scientists is reshaping the future of skincare, and learn about their remarkable discovery of OS-01, the world’s first cosmetic peptide that reverses aging at the molecular level. We’ll also explore their journey from founding to funding and their mission to transform how we think about aging and skin health. Stay tuned for an inspiring conversation with Dr. Alessandra, a leading expert in stem cell biology and skin regeneration.